Tonix Pharmaceuticals Holding Corp. Quarterly report pursuant to Section 13 or 15(d)

SUBSEQUENT EVENTS (Details Narrative) - USD ($) $ in Thousands			1 Months Ended	3 Months Ended
	Apr. 19, 2021	Sep. 04, 2020	May 10, 2021	Mar. 31, 2021	Mar. 31, 2020	Apr. 14, 2021
Net proceeds				$ 108,680	$ 16,679
Sales Agreement [Member] \| ATM [Member]
Offering price per agreement		$ 100,000
Subsequent Event [Member] \| License Agreement [Member] \| OvaGen [Member]
Shares to be issued to affiliate under agreement						2,752,294
Subsequent Event [Member] \| Sales Agreement [Member] \| ATM [Member]
Number of shares issued (in shares)			2,600,000
Net proceeds			$ 3,200
Offering price per agreement	$ 170,000